Physician

Jerome Marc Kane, M.D.

According to 2025 Medicare claims, Jerome Kane, M.D. (NPI: 1558364232) practices neurology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is MID CITIES NEUROLOGY ASSOCIATES, P.A. (NPI: 1023119336; TIN: 752600199) and primary practice location at 76021-6606. Kane is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Kane's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 973 traditional Medicare patients, billed 94,756 HCPCS/CPT codes, and received $2,871,913 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,722 prescription claims across 627 beneficiaries totaling $437,672 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). DME data shows 537 claims. Open Payments data shows 169 records totaling $3,438. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,339,033 and ending at $2,871,913. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $595,444 and ending at $437,672. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $29,916 to $48,849.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,005	56,553	$1,339,033
2016	1,041	83,908	$2,290,271
2017	1,149	77,461	$2,529,204
2018	1,179	105,764	$2,363,243
2019	1,239	150,427	$2,386,201
2020	1,107	175,533	$3,327,563
2021	1,027	155,973	$3,450,566
2022	934	100,592	$1,687,862
2023	972	45,747	$1,155,588
2024	973	94,756	$2,871,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	452	2,801	$595,444
2016	488	2,588	$416,522
2017	561	2,894	$629,742
2018	526	2,720	$1,290,512
2019	530	2,897	$1,488,141
2020	538	2,797	$1,171,987
2021	553	2,779	$974,659
2022	546	2,791	$1,014,445
2023	588	2,648	$584,820
2024	627	2,722	$437,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	214	702	$24,327
2016	161	752	$20,962
2017	125	559	$11,326
2018	86	351	$6,294
2019	99	291	$6,140
2020	44	230	$5,616
2021	64	330	$7,071
2022	38	204	$5,419
2023	132	362	$12,365
2024	146	537	$20,784

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	314	452	$87
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	129	645	$60
J0897	Injection, denosumab, 1 mg	303	23,880	$21
96372	Injection of drug or substance under skin or into muscle	341	506	$10
96127	Assessment of emotional or behavioral problems	124	129	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	48	1,008	$241,703
Horizant	Gabapentin Enacarbil	19	1,080	$22,417
Neupro	Rotigotine	16	810	$20,588
Eliquis	Apixaban	19	555	$10,889
Ajovy Syringe	Fremanezumab-Vfrm	13	378	$9,627

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0003	Lightweight wheelchair	Y	39	211	$5,601
E0988	Manual wheelchair accessory, lever-activated, wheel drive, pair	Y	N/R	16	$4,619
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	41	$1,919
E0971	Manual wheelchair accessory, anti-tipping device, each	N	22	22	$1,216
E0973	Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each	N	11	11	$1,193

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	169	$3,438	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jerome Marc Kane, M.D.?

Tedicare shows public-source Medicare data for Jerome Marc Kane, M.D. (NPI 1558364232), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jerome Marc Kane, M.D. have ACO affiliation data?

Jerome Marc Kane, M.D. is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Jerome Marc Kane, M.D.?

Jerome Marc Kane, M.D. is linked to MID CITIES NEUROLOGY ASSOCIATES, P.A. (billing NPI 1023119336) in the available physician profile data.

Does Jerome Marc Kane, M.D. have Open Payments data?

Jerome Marc Kane, M.D. has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.